돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1665309생성일: 2026년 10월 26일

6-Chloroimidazo(2,1-b)(1,3)thiazole-5-sulfonyl chloride → 1'-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]spiro[naphtho[1,2-b][1,4]oxathiine-2,4'-piperidine]-5,6-dione

https://huagongshe.com/reaction/1665309

반응식

참여 물질

역할이름HCID투입량
반응물6-Chloroimidazo(2,1-b)(1,3)thiazole-5-sulfonyl chlorideHCID 2799717—
반응물Spiro[naphtho[1,2-b][1,4]oxathiine-2,4'-piperidine]-5,6-dioneHCID 57661820—
생성물1'-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]spiro[naphtho[1,2-b][1,4]oxathiine-2,4'-piperidine]-5,6-dioneHCID 57661830—

반응 단계

Compound 77 was synthesized using spiro[naphtho[1,2-b][1,4]oxathiine-2,4′-piperidine]-5,6-dione, 6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl chloride and conditions outlined in procedure P. M.p.=265-267° C.; 400 MHz 1H NMR (DMSO-d6) δ: 8.08-8.05 (m, 1H), 7.87-7.84 (m, 1H), 7.61-7.50 (m, 3H), 7.33-7.29 (m, 1H), 3.66-3.60 (m, 2H), 3.11 (s, 2H), 3.02-2.95 (m, 2H), 2.12-2.06 (m, 2H), 1.95-1.84 (m, 2H); LCMS: 522 [M+H].

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08039503B2
출처 데이터셋uspto-grants-2011_10
ORD IDord-cf85769b0ddf479b92772d8f2ae2267c
출처 메모uspto-grants-2011_10